Author:
Doyle Shannon,Lips Esther H.,Marcus Eric,Mulder Lennart,Liu Yat-Hee,Dal Canton Francesco,Kootstra Timo,van Seijen Maartje M.,Bouybayoune Ihssane,Sawyer Elinor J.,Thompson Alastair,Pinder Sarah E.,Consortium Grand Challenge PRECISION,Sánchez Clara Isabel,Teuwen Jonas,Wesseling Jelle
Reference31 articles.
1. Ductal carcinoma in situ: to treat or not to treat, that is the question;M Van Seijen;Br J Cancer,2009
2. Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast;M Van Seijen;Br J Cancer,2021
3. Active surveillance versus treatment in low-risk DCIS: Women's preferences in the LORD-trial;Rsjm Schmitz;Eur J Cancer,2023
4. The international collaboration of active surveillance trials for low-risk DCIS;C Kanbayashi;TPS603-TPS603,2019
5. Variability in grading of ductal carcinoma in situ among an international group of pathologists;M Van Seijen;J Pathol Clin Res